bonlax s. pellegrino
sanofi s.r.l. - glicerolo - glicerolo
lattulosio pharmentis
fagit spa - lattulosio - lattulosio
lattulosio ratiopharm
ratiopharm gmbh - lattulosio - lattulosio
losartan e idroclorotiazide eg
eg s.p.a. - losartan e diuretici - losartan e diuretici
losartan e idroclorotiazide krka
krka d.d. novo mesto - losartan e diuretici - losartan e diuretici
losartan idroclorotiazide almus
almus s.r.l. - losartan e diuretici - losartan e diuretici
losartan e idroclorotiazide laboratori alter
laboratori alter s.r.l. - losartan e diuretici - losartan e diuretici
lattulosio fresenius kabi
fresenius kabi austria gmbh - lattulosio - lattulosio
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leucemia, mieloide - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
cefepima hospira
hospira italia s.r.l. - cefepima - cefepima